Clinical features of Crimean-Congo haemorrhagic fever in the United Arab Emirates

dc.contributor.author	Schwarz, TF
dc.contributor.author	Nsanze, H
dc.contributor.author	Ameen, AM
dc.date.accessioned	2013-06-10T14:30:36Z
dc.date.available	2013-06-10T14:30:36Z
dc.date.issued	1997-12
dc.identifier.citation	Infection. 1997 Nov-Dec;25(6):364-7.	en
dc.identifier.uri	http://www.ncbi.nlm.nih.gov/pubmed/9427056
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/30994
dc.description.abstract	Crimean-Congo haemorrhagic fever (C-CHF) re-emerged recently in the United Arab Emirates. The clinical outcome of 11 cases of viral haemorrhagic fever patients admitted to hospital between June 1994 and January 1995 is described. Four cases were laboratory confirmed retrospectively as C-CHF, the other patients were diagnosed likely to have the same disease on epidemiological and clinical grounds. In 72.7% of the patients, infection was fatal. Symptoms started 3.5 days before hospitalization. On admission, 81.8% of patients had high fever, 45.5% were vomiting, 63.6% had diarrhoea, 45.5% had haemorrhagic signs, and 18.2% had throat pain. Fatalities occurred 6.8 days after admission. Survivors were hospitalized for 9.3 days. Nosocomial transmission was not observed.	en
dc.language.iso	en	en
dc.publisher	University of Nairobi.	en
dc.title	Clinical features of Crimean-Congo haemorrhagic fever in the United Arab Emirates	en
dc.type	Article	en
local.publisher	Department of Medicine	en